Comment on: Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients

被引:2
|
作者
Barone, Federico [1 ,2 ]
Giacomelli, Andrea [1 ,2 ]
Casalini, Giacomo [2 ]
Corbellino, Mario
Lai, Alessia [1 ]
Gori, Andrea [1 ,3 ,4 ]
Antinori, Spinello [1 ,2 ]
机构
[1] Univ Milan, Dipartimento Sci Biomed & Clin, Milan, Italy
[2] Luigi Sacco Hosp, Infect Dis Unit 3, ASST Fatebenefratelli Sacco, Milan, Italy
[3] Luigi Sacco Hosp, Infect Dis Unit 2, ASST Fatebenefratelli Sacco, Milan, Italy
[4] Univ Milan, Ctr Multidisciplinary Res Hlth Sci MACH, Milan, Italy
关键词
D O I
10.1093/jac/dkae234
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:2400 / 2402
页数:3
相关论文
共 50 条
  • [41] Tixagevimab-Cilgavimab Decreases the Rate of SARS-CoV-2 Infection Among Solid Organ Transplant Recipients
    Sanayei, Ava M.
    Montalvan, Adriana
    Faria, Isabella
    Ochalla, Julia
    Pavlakis, Martha
    Blair, Barbra M.
    Alonso, Carolyn D.
    Curry, Michael
    Saberi, Behnam
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (08) : 1784 - 1792
  • [42] The Effectiveness of Tixagevimab/Cilgavimab (Evusheld) in Preventing Severe Sars-Cov-2 (covid) Infection After Kidney Transplantation
    Splinter, J.
    Froehlich, M.
    Kaur, P.
    Delgado-Saldana, J.
    Jaleco, M.
    Asad, S.
    Patel, S. K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S946 - S947
  • [43] The Use of Single Therapy With Tocilizumab Versus Combination Therapy With Remdesivir and Tocilizumab in SARS-CoV-2 Patients in El Paso, Texas
    Almaghlouth, Nouf K.
    Anyiam, Felix E.
    Shah, Sidra
    Haq, Syed
    Attia, Mohamed J.
    Guevara, Roberto
    Antony, Suresh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [44] Persistent detection and sequencing of SARS-CoV-2 in the bloodstream of an immunocompromised patient
    Rizzo, Alberto
    Foschi, Antonella
    Bracchitta, Fiorenza
    Faggion, Ivano
    Salari, Federica
    Borgonovo, Fabio
    Fusetti, Chiara
    Mileto, Davide
    Rizzardini, Giuliano
    Lombardi, Alessandra
    Gismondo, Maria R.
    Micheli, Valeria
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (01)
  • [45] Assessment of SARS-CoV-2 specific t-cell response in immunocompromised patients failing to seroconvert in response to sars-cov-2 vaccine
    Wiercinska, E.
    Jarisch, A.
    Daqiq-Mirdad, S.
    Hellstern, H.
    Ajib, S.
    Cremer, A.
    Nguyen, N. T. T.
    Dukat, A.
    Ullrich, E.
    Ciesek, S.
    Chow, K. -U.
    Serve, H.
    Seifried, E.
    Bader, P.
    Boenig, H.
    Bug, G.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 309 - 310
  • [46] Incidence and Features of SARS-CoV-2 Breakthrough Infection in the Hematological Conditions After Tixagevimab-Cilgavimab Prophylaxis
    Duminuco, Andrea
    Nardo, Antonella
    Orofino, Alessandra
    Giunta, Giuliana
    Conticello, Concetta
    Del Fabro, Vittorio
    Figuera, Amalia
    Chiarenza, Annalisa
    Milone, Giuseppe
    Leotta, Salvatore
    Cupri, Alessandra
    Parisi, Marina
    Mauro, Elisa
    Vetro, Calogero
    Di Raimondo, Francesco
    Romano, Alessandra
    Palumbo, Giuseppe A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S446 - S447
  • [47] SARS-CoV-2 viral dynamics in immunocompromised patients
    Caillard, Sophie
    Benotmane, Ilies
    Gautier Vargas, Gabriela
    Perrin, Peggy
    Fafi-Kremer, Samira
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (04) : 1667 - 1669
  • [48] Persistent SARS-CoV-2 Infection in a Patient with Nephrotic Syndrome under Rituximab Therapy: Successful Treatment with a Combination of Remdesivir and Monoclonal Antibodies
    Shimizu, Akihiro
    Shirai, Izumi
    Ogawa, Kyohei
    Miura, Akane
    Haruhara, Kotaro
    Oshiro, Kentaro
    Hamaguchi, Akihiko
    Yokote, Shinya
    Okabe, Masahiro
    Ueda, Hiroyuki
    Tsuboi, Nobuo
    Ikeda, Masato
    Yokoo, Takashi
    INTERNAL MEDICINE, 2022, 61 (24) : 3703 - 3708
  • [49] Viral dynamics of SARS-CoV-2 in immunocompromised patients
    Utzon, Andrea N.
    Johansen, Isik S.
    Bang, Line L.
    Pedersen, Rune M.
    Andersen, Thomas E.
    Madsen, Lone W.
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (08) : 1087.e1 - 1087.e3
  • [50] Combination Therapy With Casirivimab/Imdevimab and Remdesivir for Protracted SARS-CoV-2 Infection in B-cell-Depleted Patients
    Dioverti, M. Veronica
    Gaston, David C.
    Morris, C. Paul
    Huff, Carol Ann
    Jain, Tania
    Jones, Richard
    Anders, Viki
    Lederman, Howard
    Saunders, Jacqueline
    Mostafa, Heba H.
    Avery, Robin K.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (06):